Investigators incorporate randomized trial within dialysis care delivery
The Time to Reduce Mortality in ESRD (TiME) trial was a large pragmatic trial demonstration project designed to determine the benefits of hemodialysis sessions that are longer than many patients currently receive. The trial was conducted through a partnership between academic investigators and 2 large dialysis provider organizations using a highly centralized implementation approach. Although the trial accomplished most of its demonstration project objectives, uptake of the intervention was insufficient to determine whether longer sessions improve outcomes.
from Latest Science News -- ScienceDaily http://bit.ly/2KL6l2P
from Latest Science News -- ScienceDaily http://bit.ly/2KL6l2P
No comments: